カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のヘパリン抗凝固剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Heparin Anticoagulant Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19372）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19372
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のヘパリン抗凝固剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ヘパリン抗凝固剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のヘパリン抗凝固剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヘパリン抗凝固剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・未分画ヘパリン（UF）、低分子ヘパリン（LMWH）、超低分子ヘパリン（ULMWH）

用途別セグメントは次のように区分されます。
・生活支援施設、在宅医療、病院、老人ホーム、個人診療所

世界のヘパリン抗凝固剤市場の主要な市場プレーヤーは以下のとおりです。
・Aspen Pharmacare Holdings、Baxter International、GlaxoSmithKline、Dr. Reddy’s Laboratories、Fresenius Kabi、Leo Pharma、Mylan、Novartis、Pfizer、Sanofi、Syntex、Teva

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヘパリン抗凝固剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヘパリン抗凝固剤メーカーの企業概要、2019年～2022年までのヘパリン抗凝固剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヘパリン抗凝固剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ヘパリン抗凝固剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのヘパリン抗凝固剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヘパリン抗凝固剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヘパリン抗凝固剤の産業チェーンを掲載しています。
・第13、14、15章では、ヘパリン抗凝固剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ヘパリン抗凝固剤の概要
- 種類別分析（2017年vs2021年vs2028年）：未分画ヘパリン（UF）、低分子ヘパリン（LMWH）、超低分子ヘパリン（ULMWH）
- 用途別分析（2017年vs2021年vs2028年）：生活支援施設、在宅医療、病院、老人ホーム、個人診療所
- 世界のヘパリン抗凝固剤市場規模・予測
- 世界のヘパリン抗凝固剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Aspen Pharmacare Holdings、Baxter International、GlaxoSmithKline、Dr. Reddy’s Laboratories、Fresenius Kabi、Leo Pharma、Mylan、Novartis、Pfizer、Sanofi、Syntex、Teva
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：未分画ヘパリン（UF）、低分子ヘパリン（LMWH）、超低分子ヘパリン（ULMWH）
・用途別分析2017年-2028年：生活支援施設、在宅医療、病院、老人ホーム、個人診療所
・ヘパリン抗凝固剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヘパリン抗凝固剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヘパリン抗凝固剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヘパリン抗凝固剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ヘパリン抗凝固剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Heparin Anticoagulant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Heparin Anticoagulant market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Assisted Living Facilities accounting for % of the Heparin Anticoagulant global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Unfractionated Heparin (UF) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Heparin Anticoagulant include Aspen Pharmacare Holdings, Baxter International, GlaxoSmithKline, Dr. Reddy’s Laboratories, and Fresenius Kabi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Heparin Anticoagulant market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Unfractionated Heparin (UF)
Low Molecular Weight Heparin (LMWH)
Ultra-low Molecular Weight Heparin (ULMWH)
Market segment by Application can be divided into
Assisted Living Facilities
Home Healthcare
Hospitals
Nursing Homes and Private Clinics
The key market players for global Heparin Anticoagulant market are listed below:
Aspen Pharmacare Holdings
Baxter International
GlaxoSmithKline
Dr. Reddy’s Laboratories
Fresenius Kabi
Leo Pharma
Mylan
Novartis
Pfizer
Sanofi
Syntex
Teva
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heparin Anticoagulant product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Heparin Anticoagulant, with price, sales, revenue and global market share of Heparin Anticoagulant from 2019 to 2022.
Chapter 3, the Heparin Anticoagulant competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heparin Anticoagulant breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Heparin Anticoagulant market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Heparin Anticoagulant.
Chapter 13, 14, and 15, to describe Heparin Anticoagulant sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Heparin Anticoagulant Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Heparin Anticoagulant Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Unfractionated Heparin (UF)
1.2.3 Low Molecular Weight Heparin (LMWH)
1.2.4 Ultra-low Molecular Weight Heparin (ULMWH)
1.3 Market Analysis by Application
1.3.1 Overview: Global Heparin Anticoagulant Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Assisted Living Facilities
1.3.3 Home Healthcare
1.3.4 Hospitals
1.3.5 Nursing Homes and Private Clinics
1.4 Global Heparin Anticoagulant Market Size & Forecast
1.4.1 Global Heparin Anticoagulant Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Heparin Anticoagulant Sales in Volume (2017-2028)
1.4.3 Global Heparin Anticoagulant Price (2017-2028)
1.5 Global Heparin Anticoagulant Production Capacity Analysis
1.5.1 Global Heparin Anticoagulant Total Production Capacity (2017-2028)
1.5.2 Global Heparin Anticoagulant Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Heparin Anticoagulant Market Drivers
1.6.2 Heparin Anticoagulant Market Restraints
1.6.3 Heparin Anticoagulant Trends Analysis
2 Manufacturers Profiles
2.1 Aspen Pharmacare Holdings
2.1.1 Aspen Pharmacare Holdings Details
2.1.2 Aspen Pharmacare Holdings Major Business
2.1.3 Aspen Pharmacare Holdings Heparin Anticoagulant Product and Services
2.1.4 Aspen Pharmacare Holdings Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Baxter International
2.2.1 Baxter International Details
2.2.2 Baxter International Major Business
2.2.3 Baxter International Heparin Anticoagulant Product and Services
2.2.4 Baxter International Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Heparin Anticoagulant Product and Services
2.3.4 GlaxoSmithKline Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Dr. Reddy’s Laboratories
2.4.1 Dr. Reddy’s Laboratories Details
2.4.2 Dr. Reddy’s Laboratories Major Business
2.4.3 Dr. Reddy’s Laboratories Heparin Anticoagulant Product and Services
2.4.4 Dr. Reddy’s Laboratories Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Fresenius Kabi
2.5.1 Fresenius Kabi Details
2.5.2 Fresenius Kabi Major Business
2.5.3 Fresenius Kabi Heparin Anticoagulant Product and Services
2.5.4 Fresenius Kabi Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Leo Pharma
2.6.1 Leo Pharma Details
2.6.2 Leo Pharma Major Business
2.6.3 Leo Pharma Heparin Anticoagulant Product and Services
2.6.4 Leo Pharma Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Heparin Anticoagulant Product and Services
2.7.4 Mylan Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Heparin Anticoagulant Product and Services
2.8.4 Novartis Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Heparin Anticoagulant Product and Services
2.9.4 Pfizer Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Heparin Anticoagulant Product and Services
2.10.4 Sanofi Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Syntex
2.11.1 Syntex Details
2.11.2 Syntex Major Business
2.11.3 Syntex Heparin Anticoagulant Product and Services
2.11.4 Syntex Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Heparin Anticoagulant Product and Services
2.12.4 Teva Heparin Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Heparin Anticoagulant Breakdown Data by Manufacturer
3.1 Global Heparin Anticoagulant Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Heparin Anticoagulant Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Heparin Anticoagulant
3.4 Market Concentration Rate
3.4.1 Top 3 Heparin Anticoagulant Manufacturer Market Share in 2021
3.4.2 Top 6 Heparin Anticoagulant Manufacturer Market Share in 2021
3.5 Global Heparin Anticoagulant Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Heparin Anticoagulant Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Heparin Anticoagulant Market Size by Region
4.1.1 Global Heparin Anticoagulant Sales in Volume by Region (2017-2028)
4.1.2 Global Heparin Anticoagulant Revenue by Region (2017-2028)
4.2 North America Heparin Anticoagulant Revenue (2017-2028)
4.3 Europe Heparin Anticoagulant Revenue (2017-2028)
4.4 Asia-Pacific Heparin Anticoagulant Revenue (2017-2028)
4.5 South America Heparin Anticoagulant Revenue (2017-2028)
4.6 Middle East and Africa Heparin Anticoagulant Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Heparin Anticoagulant Sales in Volume by Type (2017-2028)
5.2 Global Heparin Anticoagulant Revenue by Type (2017-2028)
5.3 Global Heparin Anticoagulant Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Heparin Anticoagulant Sales in Volume by Application (2017-2028)
6.2 Global Heparin Anticoagulant Revenue by Application (2017-2028)
6.3 Global Heparin Anticoagulant Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Heparin Anticoagulant Sales by Type (2017-2028)
7.2 North America Heparin Anticoagulant Sales by Application (2017-2028)
7.3 North America Heparin Anticoagulant Market Size by Country
7.3.1 North America Heparin Anticoagulant Sales in Volume by Country (2017-2028)
7.3.2 North America Heparin Anticoagulant Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Heparin Anticoagulant Sales by Type (2017-2028)
8.2 Europe Heparin Anticoagulant Sales by Application (2017-2028)
8.3 Europe Heparin Anticoagulant Market Size by Country
8.3.1 Europe Heparin Anticoagulant Sales in Volume by Country (2017-2028)
8.3.2 Europe Heparin Anticoagulant Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Heparin Anticoagulant Sales by Type (2017-2028)
9.2 Asia-Pacific Heparin Anticoagulant Sales by Application (2017-2028)
9.3 Asia-Pacific Heparin Anticoagulant Market Size by Region
9.3.1 Asia-Pacific Heparin Anticoagulant Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Heparin Anticoagulant Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Heparin Anticoagulant Sales by Type (2017-2028)
10.2 South America Heparin Anticoagulant Sales by Application (2017-2028)
10.3 South America Heparin Anticoagulant Market Size by Country
10.3.1 South America Heparin Anticoagulant Sales in Volume by Country (2017-2028)
10.3.2 South America Heparin Anticoagulant Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Heparin Anticoagulant Sales by Type (2017-2028)
11.2 Middle East & Africa Heparin Anticoagulant Sales by Application (2017-2028)
11.3 Middle East & Africa Heparin Anticoagulant Market Size by Country
11.3.1 Middle East & Africa Heparin Anticoagulant Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Heparin Anticoagulant Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Heparin Anticoagulant and Key Manufacturers
12.2 Manufacturing Costs Percentage of Heparin Anticoagulant
12.3 Heparin Anticoagulant Production Process
12.4 Heparin Anticoagulant Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Heparin Anticoagulant Typical Distributors
13.3 Heparin Anticoagulant Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Heparin Anticoagulant Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Heparin Anticoagulant Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Aspen Pharmacare Holdings Basic Information, Manufacturing Base and Competitors
Table 4. Aspen Pharmacare Holdings Major Business
Table 5. Aspen Pharmacare Holdings Heparin Anticoagulant Product and Services
Table 6. Aspen Pharmacare Holdings Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Baxter International Basic Information, Manufacturing Base and Competitors
Table 8. Baxter International Major Business
Table 9. Baxter International Heparin Anticoagulant Product and Services
Table 10. Baxter International Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Heparin Anticoagulant Product and Services
Table 14. GlaxoSmithKline Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 16. Dr. Reddy’s Laboratories Major Business
Table 17. Dr. Reddy’s Laboratories Heparin Anticoagulant Product and Services
Table 18. Dr. Reddy’s Laboratories Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 20. Fresenius Kabi Major Business
Table 21. Fresenius Kabi Heparin Anticoagulant Product and Services
Table 22. Fresenius Kabi Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Leo Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Leo Pharma Major Business
Table 25. Leo Pharma Heparin Anticoagulant Product and Services
Table 26. Leo Pharma Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Mylan Basic Information, Manufacturing Base and Competitors
Table 28. Mylan Major Business
Table 29. Mylan Heparin Anticoagulant Product and Services
Table 30. Mylan Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Heparin Anticoagulant Product and Services
Table 34. Novartis Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Heparin Anticoagulant Product and Services
Table 38. Pfizer Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Sanofi Basic Information, Manufacturing Base and Competitors
Table 40. Sanofi Major Business
Table 41. Sanofi Heparin Anticoagulant Product and Services
Table 42. Sanofi Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Syntex Basic Information, Manufacturing Base and Competitors
Table 44. Syntex Major Business
Table 45. Syntex Heparin Anticoagulant Product and Services
Table 46. Syntex Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Teva Basic Information, Manufacturing Base and Competitors
Table 48. Teva Major Business
Table 49. Teva Heparin Anticoagulant Product and Services
Table 50. Teva Heparin Anticoagulant Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Heparin Anticoagulant Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Heparin Anticoagulant Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Heparin Anticoagulant, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Heparin Anticoagulant Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Heparin Anticoagulant Production Site of Key Manufacturer
Table 56. Heparin Anticoagulant New Entrant and Capacity Expansion Plans
Table 57. Heparin Anticoagulant Mergers & Acquisitions in the Past Five Years
Table 58. Global Heparin Anticoagulant Sales by Region (2017-2022) & (K Units)
Table 59. Global Heparin Anticoagulant Sales by Region (2023-2028) & (K Units)
Table 60. Global Heparin Anticoagulant Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Heparin Anticoagulant Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Heparin Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 63. Global Heparin Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 64. Global Heparin Anticoagulant Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Heparin Anticoagulant Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Heparin Anticoagulant Price by Type (2017-2022) & (US$/Unit)
Table 67. Global Heparin Anticoagulant Price by Type (2023-2028) & (US$/Unit)
Table 68. Global Heparin Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 69. Global Heparin Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 70. Global Heparin Anticoagulant Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Heparin Anticoagulant Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Heparin Anticoagulant Price by Application (2017-2022) & (US$/Unit)
Table 73. Global Heparin Anticoagulant Price by Application (2023-2028) & (US$/Unit)
Table 74. North America Heparin Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 75. North America Heparin Anticoagulant Sales by Country (2023-2028) & (K Units)
Table 76. North America Heparin Anticoagulant Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Heparin Anticoagulant Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Heparin Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 79. North America Heparin Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 80. North America Heparin Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 81. North America Heparin Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 82. Europe Heparin Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 83. Europe Heparin Anticoagulant Sales by Country (2023-2028) & (K Units)
Table 84. Europe Heparin Anticoagulant Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Heparin Anticoagulant Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Heparin Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 87. Europe Heparin Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 88. Europe Heparin Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 89. Europe Heparin Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Heparin Anticoagulant Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Heparin Anticoagulant Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Heparin Anticoagulant Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Heparin Anticoagulant Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Heparin Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Heparin Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Heparin Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Heparin Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 98. South America Heparin Anticoagulant Sales by Country (2017-2022) & (K Units)
Table 99. South America Heparin Anticoagulant Sales by Country (2023-2028) & (K Units)
Table 100. South America Heparin Anticoagulant Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Heparin Anticoagulant Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Heparin Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 103. South America Heparin Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 104. South America Heparin Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 105. South America Heparin Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Heparin Anticoagulant Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Heparin Anticoagulant Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Heparin Anticoagulant Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Heparin Anticoagulant Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Heparin Anticoagulant Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Heparin Anticoagulant Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Heparin Anticoagulant Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Heparin Anticoagulant Sales by Application (2023-2028) & (K Units)
Table 114. Heparin Anticoagulant Raw Material
Table 115. Key Manufacturers of Heparin Anticoagulant Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Heparin Anticoagulant Typical Distributors
Table 119. Heparin Anticoagulant Typical Customers
List of Figures
Figure 1. Heparin Anticoagulant Picture
Figure 2. Global Heparin Anticoagulant Revenue Market Share by Type in 2021
Figure 3. Unfractionated Heparin (UF)
Figure 4. Low Molecular Weight Heparin (LMWH)
Figure 5. Ultra-low Molecular Weight Heparin (ULMWH)
Figure 6. Global Heparin Anticoagulant Revenue Market Share by Application in 2021
Figure 7. Assisted Living Facilities
Figure 8. Home Healthcare
Figure 9. Hospitals
Figure 10. Nursing Homes and Private Clinics
Figure 11. Global Heparin Anticoagulant Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Heparin Anticoagulant Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Heparin Anticoagulant Sales (2017-2028) & (K Units)
Figure 14. Global Heparin Anticoagulant Price (2017-2028) & (US$/Unit)
Figure 15. Global Heparin Anticoagulant Production Capacity (2017-2028) & (K Units)
Figure 16. Global Heparin Anticoagulant Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Heparin Anticoagulant Market Drivers
Figure 18. Heparin Anticoagulant Market Restraints
Figure 19. Heparin Anticoagulant Market Trends
Figure 20. Global Heparin Anticoagulant Sales Market Share by Manufacturer in 2021
Figure 21. Global Heparin Anticoagulant Revenue Market Share by Manufacturer in 2021
Figure 22. Heparin Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Heparin Anticoagulant Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Heparin Anticoagulant Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Heparin Anticoagulant Sales Market Share by Region (2017-2028)
Figure 26. Global Heparin Anticoagulant Revenue Market Share by Region (2017-2028)
Figure 27. North America Heparin Anticoagulant Revenue (2017-2028) & (USD Million)
Figure 28. Europe Heparin Anticoagulant Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Heparin Anticoagulant Revenue (2017-2028) & (USD Million)
Figure 30. South America Heparin Anticoagulant Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Heparin Anticoagulant Revenue (2017-2028) & (USD Million)
Figure 32. Global Heparin Anticoagulant Sales Market Share by Type (2017-2028)
Figure 33. Global Heparin Anticoagulant Revenue Market Share by Type (2017-2028)
Figure 34. Global Heparin Anticoagulant Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Heparin Anticoagulant Sales Market Share by Application (2017-2028)
Figure 36. Global Heparin Anticoagulant Revenue Market Share by Application (2017-2028)
Figure 37. Global Heparin Anticoagulant Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Heparin Anticoagulant Sales Market Share by Type (2017-2028)
Figure 39. North America Heparin Anticoagulant Sales Market Share by Application (2017-2028)
Figure 40. North America Heparin Anticoagulant Sales Market Share by Country (2017-2028)
Figure 41. North America Heparin Anticoagulant Revenue Market Share by Country (2017-2028)
Figure 42. United States Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Heparin Anticoagulant Sales Market Share by Type (2017-2028)
Figure 46. Europe Heparin Anticoagulant Sales Market Share by Application (2017-2028)
Figure 47. Europe Heparin Anticoagulant Sales Market Share by Country (2017-2028)
Figure 48. Europe Heparin Anticoagulant Revenue Market Share by Country (2017-2028)
Figure 49. Germany Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Heparin Anticoagulant Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Heparin Anticoagulant Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Heparin Anticoagulant Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Heparin Anticoagulant Revenue Market Share by Region (2017-2028)
Figure 58. China Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Heparin Anticoagulant Sales Market Share by Type (2017-2028)
Figure 65. South America Heparin Anticoagulant Sales Market Share by Application (2017-2028)
Figure 66. South America Heparin Anticoagulant Sales Market Share by Country (2017-2028)
Figure 67. South America Heparin Anticoagulant Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Heparin Anticoagulant Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Heparin Anticoagulant Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Heparin Anticoagulant Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Heparin Anticoagulant Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Heparin Anticoagulant Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Heparin Anticoagulant in 2021
Figure 79. Manufacturing Process Analysis of Heparin Anticoagulant
Figure 80. Heparin Anticoagulant Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のプレフィルドヘパリンフラッシュシリンジ市場2022年：市場規模予測（～2028年）
  • 抗凝固薬の世界市場2023年：注射用抗凝固薬、経口抗凝固薬
  • ヘパリンコート眼内レンズのグローバル市場展望 2023年-2029年：プレロード眼内レンズ、非プレロード眼内レンズ
  • ヘパリンキャップの世界市場 2022年-2026年
  • ヘパリンのグローバル市場展望 2023年-2029年：ナトリウム、カルシウム
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19372 )"世界のヘパリン抗凝固剤市場2022年：市場規模予測（～2028年）" (英文：Global Heparin Anticoagulant Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。